Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review

July 2021 | 23 pages | ID: A1E9D91DB3AEN
GlobalData

Abstracts

Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Avanir Pharmaceuticals Inc (Avanir), a subsidiary of Otsuka Pharmaceutical Co Ltd. is a biopharmaceutical company that focuses on the research, development and commercialization of medical and pharmaceutical treatments for central nervous system disorders. The company’s lead product include Nuedexta, a medication used for the treatment of pseudobulbar affect (PBA). The company's pipeline product include AVP-786 intended for the treatment of agitation in Alzheimer’s disease, residual schizophrenia, intermittent explosive disorder, disinhibition in dementia and traumatic brain injury behavioural dysfunction, among others. Avanir is headquartered in Aliso Viejo, California, the US.

Avanir Pharmaceuticals Inc Key Recent Developments

Apr 19,2021: Avanir joins Decentralized Trials & Research Alliance (DTRA) as a founding member to advance access to clinical trials

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Avanir Pharmaceuticals Inc - Key Facts
Avanir Pharmaceuticals Inc - Key Employees
Avanir Pharmaceuticals Inc - Key Employee Biographies
Avanir Pharmaceuticals Inc - Major Products and Services
Avanir Pharmaceuticals Inc - History
Avanir Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Avanir Pharmaceuticals Inc - Business Description
Avanir Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Avanir Pharmaceuticals Inc - Strengths
Avanir Pharmaceuticals Inc - Weaknesses
Avanir Pharmaceuticals Inc - Opportunities
Avanir Pharmaceuticals Inc - Threats
Avanir Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Avanir Pharmaceuticals Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Apr 19, 2021: Avanir joins Decentralized Trials & Research Alliance (DTRA) as a founding member to advance access to clinical trials

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Avanir Pharmaceuticals Inc, Key Facts
Avanir Pharmaceuticals Inc, Key Employees
Avanir Pharmaceuticals Inc, Key Employee Biographies
Avanir Pharmaceuticals Inc, Major Products and Services
Avanir Pharmaceuticals Inc, History
Avanir Pharmaceuticals Inc, Subsidiaries
Avanir Pharmaceuticals Inc, Key Competitors
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Avanir Pharmaceuticals Inc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021